Aviragen Therapeutics licenses Georgia State Technology to develop antiviral therapies

(Georgia State University) The Georgia State University Research Foundation has entered into a licensing and sponsored research agreement with Aviragen Therapeutics, Inc., a Georgia-based pharmaceutical company developing the next generation of antivirals, to develop and commercialize respiratory syncytial virus replication inhibitors.